Is Liver Biopsy a Gold or an Old Standard in NAFL and NASH?


Liver Biopsy Article Photo

In this International Biopharmaceutical Industry article, Scott Beasley and Rafal Ziecina M.D., Ph.D., discuss how non-invasive imaging is replacing liver biopsy as the gold standard for evaluation of fibrosis in non-alcoholic fatty liver disease (NAFLD).

On-Demand Webinars

[On-Demand Webinar] Accelerating Your Journey to Approval

Clinical Research, Early Phase

accelerating your journey to approval webinar

Are you seeking a faster route to approval? Watch both sessions from our virtual event, highlighting alternatives to the traditional development path: There Can Only Be One: How to Achieve First to File Status and Zero Waste: The Quickest Path from Pilot to Pivotal.